Oncology Letters

Papers
(The H4-Index of Oncology Letters is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
[Corrigendum] Molecular heterogeneity of guanine nucleotide binding‑protein γ subunit 4 in left‑ and right‑sided colon cancer61
Metanephric adenoma in children: A case report and literature review51
A pilot study on the detection of microsatellite instability using long mononucleotide repeats in solid tumors45
Synchronous primary colorectal mucinous adenocarcinoma and pancreatic ductal adenocarcinoma: A case report44
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi‑institutional study43
Benefits of adjuvant treatment with the Pingxiao capsule in patients with early breast cancer: A single‑center retrospective cohort study42
Immunoexpression of p62/SQSTM1/Sequestosome‑1 in human primary and recurrent IDH1/2 wild‑type glioblastoma: A pilot study40
Long‑term progression‑free survival in HR+/HER2+ advanced breast cancer with combination therapy with a CDK4/6 inhibitor and first‑line maintenance therapy: A case report36
Proteomics analysis reveals elevated RAB21 in serum‑derived extracellular vesicles from patients with follicular thyroid carcinoma34
Primary gingival diffuse large B‑cell lymphoma with muscle invasion: A case report34
Immune checkpoint inhibitors with or without radiotherapy in metastatic non‑small cell lung cancer: A meta‑analysis and literature review33
Imaging assessment of tumor densities and sizes following pazopanib treatment for central nervous system solitary fibrous tumors with multiple extracranial metastases: A case series33
Metastatic squamous cell carcinoma in the residual spleen diagnosed with emergency ultrasonography: A case report33
Primary osteosarcoma of the kidney: A case report30
CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated30
[Retracted] Treatment with a selenium‑platinum compound induced T‑cell acute lymphoblastic leukemia/lymphoma cells apoptosis through the mitochondrial signaling pathway29
Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma28
Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis28
Novel therapeutic strategies for non‑small cell lung cancer: Combination therapies with immune checkpoint inhibitors (Review)28
Novel predictive nomograms based on aspartate aminotransferase‑to‑platelet ratio index for hepatocellular carcinoma with post‑operative adjuvant transarterial chemoembolization28
Prediction and verification of the prognostic biomarker SLC2A2 and its association with immune infiltration in gastric cancer28
Non‑surgical breast‑conserving treatment using Kochi oxydol‑radiation therapy for unresectable carcinomas II for patients with stage 0 to IIIC breast cancer27
Prognostic value of moderate or massive ascites in patients with advanced gastric cancer27
Cancer marker TNFRSF1A: From single‑cell heterogeneity of renal cell carcinoma to functional validation26
Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib25
Successful treatment with trastuzumab plus chemotherapy as the first‑line regimen in advanced small bowel adenocarcinoma harboring HER2 amplification: A report of two cases25
0.063233852386475